Bowhead Specialty (NYSE:BOW) Given New $25.00 Price Target at Morgan Stanley

Bowhead Specialty (NYSE:BOW) had its target price dropped by analysts at Morgan Stanley from $27.00 to $25.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 12.11% from the company’s current price.

BOW has been the subject of several other reports. Piper Sandler raised their price target on Bowhead Specialty from $30.00 to $32.00 and gave the stock an “overweight” rating in a research report on Monday, December 22nd. Keefe, Bruyette & Woods raised Bowhead Specialty from a “moderate buy” rating to a “strong-buy” rating in a research note on Monday, March 16th. Weiss Ratings restated a “hold (c-)” rating on shares of Bowhead Specialty in a report on Friday, March 27th. Royal Bank Of Canada dropped their target price on Bowhead Specialty from $33.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. Finally, Zacks Research upgraded shares of Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research note on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Bowhead Specialty has a consensus rating of “Moderate Buy” and a consensus target price of $32.67.

Bowhead Specialty Trading Down 0.4%

Shares of Bowhead Specialty stock traded down $0.09 on Monday, reaching $22.30. The company had a trading volume of 8,549 shares, compared to its average volume of 215,151. The firm’s 50 day moving average price is $23.81 and its two-hundred day moving average price is $25.53. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.52 and a current ratio of 0.52. Bowhead Specialty has a 52-week low of $21.21 and a 52-week high of $41.98. The firm has a market cap of $732.33 million, a PE ratio of 14.03, a PEG ratio of 0.68 and a beta of -0.49.

Bowhead Specialty (NYSE:BOW) last posted its earnings results on Tuesday, February 24th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.02. The firm had revenue of $151.68 million during the quarter, compared to the consensus estimate of $145.99 million. Bowhead Specialty had a net margin of 9.75% and a return on equity of 13.27%. Sell-side analysts predict that Bowhead Specialty will post 1.36 earnings per share for the current fiscal year.

Institutional Trading of Bowhead Specialty

Several institutional investors have recently modified their holdings of BOW. Langdon Equity Partners acquired a new position in shares of Bowhead Specialty in the 4th quarter valued at $28,000. Raymond James Financial Inc. purchased a new position in shares of Bowhead Specialty in the 2nd quarter valued at $52,000. CWM LLC raised its stake in Bowhead Specialty by 257.7% during the 4th quarter. CWM LLC now owns 1,481 shares of the company’s stock worth $42,000 after acquiring an additional 1,067 shares in the last quarter. State of Alaska Department of Revenue acquired a new stake in Bowhead Specialty during the 3rd quarter worth $42,000. Finally, Tower Research Capital LLC TRC lifted its position in Bowhead Specialty by 99.0% in the second quarter. Tower Research Capital LLC TRC now owns 1,926 shares of the company’s stock valued at $72,000 after acquiring an additional 958 shares during the last quarter.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.